China
Hillhouse invests $400m in China data center player
Hillhouse Capital has taken a 3.9% interest in US-listed Chinese data center developer GDS Holdings for $400 million.
VC-backed SinocellTech enjoys strong Star Market debut
Chinese drug developer SinocellTech nearly trebled in value on its first day of trading on China's Science and Technology Innovation Board (Star Market) following a RMB1.28 billion ($181 million) IPO.
Blackstone invests $150m in China's 21Vianet
The Blackstone Group has invested $150 million in 21Vianet, a US-listed Chinese data center developer backed by Singapore’s Temasek Holdings.
Chinese IPOs: One less option
Will Chinese companies listed in the US become the latest casualties of tensions between the two countries? It could lead to a narrowing in IPO exit options for PE and VC investors
Deal focus: Yidui delivers love by video
Sky9 Capital and Xiaomi have thrown their support behind a Chinese video-dating platform designed for Generation Z, complete with virtual meeting rooms, live audiences, and mechanisms for crashing other people's dates
Chinese car parts supplier Casstime raises $50m
Chinese aftermarket car parts supplier Casstime has raised $50 million in the second tranche of Series C round led by Greater Bay Area Homeland Investments.
China's Genetron trades flat after upsizing US IPO
Genetron Holdings, a Chinese company that uses DNA sequencing to support the diagnosis and treatment of cancer, traded flat on its NASDAQ debut following a larger-than-planned $256 million IPO.
China logistics robot specialist raises $200m Series C
Geek+, a manufacturer of robots used to move merchandise around warehouses, has closed a Series C funding round, having raised $200 million across two tranches.
China gay dating app Blued pursues US IPO
BlueCity Holdings, the company behind Chinese gay dating platform Blued, has filed an application to list on NASDAQ, which would provide a liquidity event for several PE and VC investors.
GP Profile: Gobi Partners
China’s Gobi Partners has grown from a four-person team to an 11-office franchise. The coming decade will test the VC firm’s aspiration to become a pan-Asian enterprise
Fund focus: Cathay taps strategic expertise in energy
Cathay Capital Private Equity is raising what it claims is China's first-ever smart energy fund, relying on contributions from LPs that offer strategic as well as financial support
Ascendent to exit China dairy player through $240m trade sale
Ascendent Capital Partners has agreed to make a full exit from Chinese dairy producer Ningxia Harmony Dairy Development with New Hope Dairy set to buy the business for an enterprise valuation of RMB1.7 billion ($240 million).
Chinese cloud player Qiniu gets $141m Series F
Chinese enterprise cloud service provider Qiniu Cloud has raised RMB1 billion ($141 million) in Series F funding from the state-owned China Structural Reform Fund, Bocom International, and Hongzhao Fund.
China's Miaoshou Doctor raises $85m
Miaoshou Doctor, a Chinese online healthcare services platform, has raised RMB600 million ($85 million) in the first tranche of Series D funding round backed by the likes of Qiming Venture Partners, Sequoia Capital China, Ince Capital Partners, CITIC...
Chinese AI chip maker Biren raises $155m Series A
Biren Technology, a nine-month-old Chinese smart chip design company, has raised RMB1.1 billion ($155 million) in Series A funding led by Qiming Venture Partners, IDG Capital and Walden International.
PE investors agree $8.7b take-private of China's 58.com
58.com, China’s leading online classifieds marketplace, has agreed to be acquired by a consortium of private equity investors at an implied equity valuation of $8.7 billion.
BOC leads Series B-plus for Chinese AI player Shukun
Shukun, a Chinese start-up that develops artificial intelligence (AI) technology used in the diagnosis of cardiovascular diseases, has raised RMB200 million ($28 million) in an extended Series B round led by BOC International and CCB International.
Foreign investment restrictions: Looking inward
China is the implied threat as governments look to protect vulnerable domestic companies from foreign corporate raiders. On balance, PE investors are unlikely to benefit from moves towards de-globalization
Asia gyms: Muscling through the mire
Fitness centers have continued to woo investors during COVID-19 despite patchy progress in the reopening of gyms and difficult-to-digitize business models
China's Burning Rock soars on debut after $222m US IPO
Burning Rock Biotech, a venture capital-backed, China-based provider of genetic testing services used in cancer diagnosis, rose 49% on its trading debut following a $222.8 million US IPO.
Chinese instant food brand Baijia raises $28m
Chinese instant food brand Baijia Food has raised RMB200 million ($28 million) in Series B funding led by GL Ventures, the venture capital arm of Hillhouse Capital.
Matrix China raises $750m for Fund VI
Matrix Partners China has raised $750 million for its sixth venture capital fund for deployment in early-stage opportunities across the internet and mobile internet, financial services, healthcare, and enterprises services spaces.
CPE, Mirae lead $100m Series B for China's JW Therapeutics
JW Therapeutics, a China cancer treatment specialist established by Bristol Myers Squibb-owned Juno Therapeutics and China’s WuXi AppTec, has received $100 million in Series B funding.
China social e-commerce player Tongcheng Life gets $200m
Tongcheng Life, a social e-commerce business incubated by online travel agency Tongcheng-Elong, has raised a $200 million Series C round led by Joyy, previously known as YY, a US-listed video-based social media platform.